These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Comparative antihypertensive effects of guanabenz and methyldopa. Walker BR; Deitch MW; Schneider BE; Hare LE Clin Ther; 1981; 4(4):275-84. PubMed ID: 7332915 [TBL] [Abstract][Full Text] [Related]
26. [Withdrawal of drug addicts from opiates in general hospitals. Value of clonidine--30 cases]. Lambert H; Kierzek B; Demogeot C; Larcan A Therapie; 1984; 39(4):411-9. PubMed ID: 6484885 [No Abstract] [Full Text] [Related]
27. Central alpha 2 receptors and the regulation of blood pressure in humans. Reid JL J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S45-50. PubMed ID: 2417053 [TBL] [Abstract][Full Text] [Related]
28. Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study. Uhde TW; Redmond DE; Kleber HD Psychiatry Res; 1980 Mar; 2(1):37-47. PubMed ID: 6932053 [TBL] [Abstract][Full Text] [Related]
29. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification. Gossop M; Strang J Br J Psychiatry; 1991 May; 158():697-9. PubMed ID: 1860023 [TBL] [Abstract][Full Text] [Related]
30. [Effect of guanabenz, alpha 2 central agonist, on the activity of the sympathetic nervous system during dynamic and isometric physical exercise]. Fariello R; Agabiti-Rosei E; Alicandri C; Romanelli G; Muiesan G; Renzetti I Minerva Cardioangiol; 1984 May; 32(5):273-9. PubMed ID: 6382054 [No Abstract] [Full Text] [Related]
31. [Effects of clonidine on opiate withdrawal symptoms. Results - biochemical mechanisms (author's transl)]. Girard M; Escande M; Granier F; Gardes JP Encephale; 1982; 8(1):37-48. PubMed ID: 6284474 [TBL] [Abstract][Full Text] [Related]
32. Pharmacologic interventions for the treatment of opioid dependence and withdrawal. Guthrie SK DICP; 1990; 24(7-8):721-34. PubMed ID: 2197814 [TBL] [Abstract][Full Text] [Related]
33. Self-administration of clonidine and oxazepam by methadone detoxification patients. Preston KL; Bigelow GE; Liebson IA NIDA Res Monogr; 1984 Mar; 49():192-8. PubMed ID: 6434959 [No Abstract] [Full Text] [Related]
34. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Honey BL; Benefield RJ; Miller JL; Johnson PN Ann Pharmacother; 2009 Sep; 43(9):1506-11. PubMed ID: 19690220 [TBL] [Abstract][Full Text] [Related]
35. Long-term therapy of hypertension with guanabenz. Walker BR; Deitch MW; Schneider BE; Hare LE; Gold JA Clin Ther; 1981; 4(3):217-28. PubMed ID: 7307037 [TBL] [Abstract][Full Text] [Related]
36. [Guanabenz acetate and serum lipids. Sequential evaluation during one year]. Spritzer N; Spritzer TS; Rodrigues R Arq Bras Cardiol; 1988 Aug; 51(2):193-7. PubMed ID: 3075114 [No Abstract] [Full Text] [Related]
37. Withdrawal syndrome following cessation of guanabenz therapy. Ram CV; Holland OB; Fairchild C; Gomez-Sanchez CE J Clin Pharmacol; 1979; 19(2-3):148-50. PubMed ID: 422739 [TBL] [Abstract][Full Text] [Related]
38. Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts. Camí J; Gilabert M; San L; de la Torre R Br J Addict; 1992 Aug; 87(8):1145-51. PubMed ID: 1511228 [TBL] [Abstract][Full Text] [Related]
39. Withdrawal from heroin and methadone. Travers R Br J Psychiatry; 1991 Oct; 159():582-3. PubMed ID: 1751876 [No Abstract] [Full Text] [Related]
40. Comparison of guanabenz and clonidine in hypertensive patients. Kluyskens Y; Snoeck J Curr Med Res Opin; 1980; 6(9):638-43. PubMed ID: 6996935 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]